Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 61 AL 75

Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers

D'Aversa E, Grisafi M, Pernagallo S, Salvatori F, Singh AV, Nucciarone A, Tisato V, Gemmati D.

Front Aging Neurosci. 2026 Oct 5;18:1959361. doi: 10.3389/fnagi.2026.1959361. eCollection 2026.

Sleep Spindles and Slow Oscillations as Potential Biomarkers and Therapeutic Targets in Mild-to-Moderate Alzheimer's Disease

Páez A, Piñol-Ripoll G, Dakterzada F, Dang-Vu TT.

Curr Neurol Neurosci Rep. 2026 Oct 20;26(1):58. doi: 10.1007/s11910-026-01528-9.

More than just accuracy: A pathway-level framework for implementing blood and digital biomarkers for Alzheimer's disease care

Perneczky R, Schöll M, Rauchmann BS, Hofmann A.

Neuron. 2026 Oct 20:S0896-6273(26)00689-6. doi: 10.1016/j.neuron.2026.09.006. Online ahead of print.

Biomarker profiles in late-life depression and Alzheimer's disease across and beyond the A/T/N framework: A scoping review

Zhu Y, Damera N, Singh RK, Bekena S, Kelble L, McGuire K, Hu Y, Mersiehazen E, Vijay G, Nazif A, Kolady R, Xiang L, Liu X, Flores S, Dombrowski K, Pal S, Hardi A, Taylor K, Trani JF, Ances BM, Lenze EJ, Vemuri P, Jack CR Jr, Petersen RC, Babulal GM.

Alzheimers Dement. 2026 Oct;22(10):e71739. doi: 10.1002/alz.71739.

Association Between Plasma N-Terminal Tau, Cognitive Decline, and Neurodegeneration in the ADNI Cohort

Rao Y, Liu L, Ostaszewski BL, Anderson AK, Pinilla V, Shirzadi Z, Laho EM, Stern AM, Yau WW, Yang HS, Buckley RF, Ashton NJ, Denkinger MN, Sperling RA, Selkoe DJ, Chhatwal JP, Schultz SA; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2026 Nov 24;107(10):e218564. doi: 10.1212/WNL.0000000000218564. Epub 2026 Oct 21.

Noninvasive diagnosis of Alzheimer's disease: a review of emerging biomarkers and multimodal approaches

Zhao J, Nie C, Gao R, Hu Z, Lin Y.

Front Cell Dev Biol. 2026 Oct 8;14:1964029. doi: 10.3389/fcell.2026.1964029. eCollection 2026.

Real-world clinical, biomarker, and imaging outcomes of lecanemab in Alzheimer's disease: a multicenter longitudinal cohort study in Jiangsu, China

Tang L, Chen X, Zhang L, Fan L, Chen N, Li C, Cai Z, Chen G, Chen H, Ye M, Zheng H, Li Q, Ke Z, Hu Z, Cao M, Yang D, Xu S, Xie C, Li X, Xu X, Yu M, Lian X, Hu H, Li H, Cai X, Chen H, Xu W, Cui G, Zhao Y, Dong J, Zhang L, Zhu X, Zhao H, Xu Y.

Alzheimers Dement. 2026 Oct;22(10):e71936. doi: 10.1002/alz.71936.

Pathway-specific polygenic risk scores modify the association between amyloid and tau PET accumulation in patients with Alzheimer's disease

Valentim C, Denecke J, Frerich S, Betthauser TJ, Li Y, Ahmadi R, Franzmeier N; Alzheimer's Disease Neuroimaging Initiative (ADNI); Malik R, Ewers M.

Alzheimers Dement. 2026 Oct;22(10):e71939. doi: 10.1002/alz.71939.

Short-interval variability and test-retest reliability of Alzheimer's disease plasma biomarkers in a clinically heterogenous cohort

Beament M, Wiltshire K, Belder CRS, Abel E, Hart M, Heslegrave AJ, Lunn MP, Rosa-Grilo M, Swann O, Schott JM, Zetterberg H, Fox NC, Keshavan A.

Alzheimers Res Ther. 2026 Oct 27;18(1):238. doi: 10.1186/s13195-026-02180-8.

Blood-Based Biomarkers in Alzheimer's Disease: Advances in Detection Technologies and Clinical Applications

Li S, Huang L, Guo Q.

Aging Med (Milton). 2026 Oct 27:10.1002/agm2.70112. doi: 10.1002/agm2.70112. Online ahead of print.

A prospective observational study measuring the stability of plasma pTau181 using the Elecsys Phospho-Tau (181P) plasma immunoassay for early detection of Alzheimer's disease

Kurz C, Leonhardt S, Hufnagel A, Wizemann S, Deutelmoser H, Menzel P, Perneczky R.

Alzheimers Res Ther. 2026 Oct 24;18(1):240. doi: 10.1186/s13195-026-02238-7.

Alzheimer's disease subtyping approaches and the role of co-pathologies

Gawor K, Statz K, Schaeverbeke J, Thal DR.

Brain. 2026 Sep 7;149(9):2936-2954. doi: 10.1093/brain/awag157.

Comparative risk of amyloid-related imaging abnormalities with anti-amyloid-β monoclonal antibodies: A systematic review and penalized likelihood network meta-analysis of randomized trials

Sharma A, Suresh V, Kola PR, Raj R, Javairia F, Nithyanandam A, Kaur A, Arora H, Uwishema O, Gorty D, Beriwal N, Verma A, Qidwai K, Singh Malhotra H, Kumar Garg R.

J Alzheimers Dis. 2026 Sep;113(1):65-82. doi: 10.1177/13872877261466097. Epub 2026 Jul 11.

Chronic schizophrenia versus Alzheimer's disease: neuroimaging perspectives on the late-life course of schizophrenia

Noroozian M, Givian H, Vafaee MS.

J Neural Transm (Vienna). 2026 Aug;133(8):1953-1962. doi: 10.1007/s00702-026-03230-z. Epub 2026 Jul 23.

Passive Digital Marker-enabled identification and engagement for Alzheimer's disease and related dementias care in primary care: the INCLUDE study protocol

Summanwar D, Lee L, Willis DR, Ben Miled Z, Baucco C, Webber ECC, Perkins AJ, Powell AY, Fowler NR.

BMJ Open. 2026 Sep 8;16(9):e116755. doi: 10.1136/bmjopen-2026-116755.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias